Skip to main content

Table 5 Graft survival rates at year 1, 2, and 3

From: Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study

Graft survival rate

rATG

IL2-RA

P

Year 1

37 (100.0)

123 (97.6)

1.000

Year 2

21 (100.0)

73 (96.1)

1.000

Year 3

10 (100.0)

44 (93.6)

1.000